Global OTC Gastrointestinal Products Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global OTC Gastrointestinal Products Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.
OTC Gastrointestinal Products report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Gastrointestinal Products market is projected to reach US$ 8483.1 million in 2034, increasing from US$ 5900.7 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Drug Stores are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for OTC Gastrointestinal Products industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, OTC Gastrointestinal Products key manufacturers include GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer and Bristol-Myers Squibb, etc. GlaxoSmithKline, Merck, Novartis are top 3 players and held % sales share in total in 2022.
OTC Gastrointestinal Products can be divided into H2 Receptor Antagonists and Proton Pump Inhibitors (PPIs), etc. H2 Receptor Antagonists is the mainstream product in the market, accounting for % sales share globally in 2022.
OTC Gastrointestinal Products is widely used in various fields, such as Hospital Pharmacies, Drug Stores, Retail Stores and E-Commerce, etc. Hospital Pharmacies provides greatest supports to the OTC Gastrointestinal Products industry development. In 2022, global % sales of OTC Gastrointestinal Products went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Gastrointestinal Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
GlaxoSmithKline
Merck
Novartis
Bayer
Pfizer
Bristol-Myers Squibb
Segment by Type
H2 Receptor Antagonists
Proton Pump Inhibitors (PPIs)
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the OTC Gastrointestinal Products market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of OTC Gastrointestinal Products, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the OTC Gastrointestinal Products industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of OTC Gastrointestinal Products in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, OTC Gastrointestinal Products introduction, etc. OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of OTC Gastrointestinal Products market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
OTC Gastrointestinal Products report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Gastrointestinal Products market is projected to reach US$ 8483.1 million in 2034, increasing from US$ 5900.7 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Drug Stores are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for OTC Gastrointestinal Products industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, OTC Gastrointestinal Products key manufacturers include GlaxoSmithKline, Merck, Novartis, Bayer, Pfizer and Bristol-Myers Squibb, etc. GlaxoSmithKline, Merck, Novartis are top 3 players and held % sales share in total in 2022.
OTC Gastrointestinal Products can be divided into H2 Receptor Antagonists and Proton Pump Inhibitors (PPIs), etc. H2 Receptor Antagonists is the mainstream product in the market, accounting for % sales share globally in 2022.
OTC Gastrointestinal Products is widely used in various fields, such as Hospital Pharmacies, Drug Stores, Retail Stores and E-Commerce, etc. Hospital Pharmacies provides greatest supports to the OTC Gastrointestinal Products industry development. In 2022, global % sales of OTC Gastrointestinal Products went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Gastrointestinal Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GlaxoSmithKline
Merck
Novartis
Bayer
Pfizer
Bristol-Myers Squibb
Segment by Type
H2 Receptor Antagonists
Proton Pump Inhibitors (PPIs)
Segment by Application
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the OTC Gastrointestinal Products market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of OTC Gastrointestinal Products, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the OTC Gastrointestinal Products industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of OTC Gastrointestinal Products in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, OTC Gastrointestinal Products introduction, etc. OTC Gastrointestinal Products Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of OTC Gastrointestinal Products market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices